跳至主要内容
临床试验/NCT06403787
NCT06403787已完成2 期

Effect of Implementing an Aerobic Training Program and Administering Ginkgo Biloba Extract on Plasma Concentrations of LDL and HDL in HIV Positive Patients Undergoing Antiretroviral Treatment at the HIV Unit of Hospital Civil Fray Antonio Alcalde

University of Guadalajara1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2022年5月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
28
试验地点
1
主要终点
Comparison of changes in serum lipid levels.

研究概览

简要总结

The administration of antiretroviral drugs (ART) has significantly prolonged the life expectancy of people living with human immunodeficiency virus (HIV) and delayed the progression towards Acquired Immune Deficiency Syndrome (AIDS). However, this has led to the emergence of other conditions, such as dyslipidemia, among individuals undergoing ART. Dyslipidemia is commonly managed with statin therapy, which has not been reported to have pharmacological interactions with ART. Additionally, ginkgo biloba extract (GBS) has been observed to improve blood lipid concentrations, and aerobic exercise training (EXA) interventions have shown positive modifications in these values.

Given this context, the present study aims to investigate the potential positive effects of an aerobic training program and the consumption of ginkgo biloba extract on plasma lipid concentrations in HIV-positive individuals. The study seeks to provide insights into novel strategies for managing dyslipidemia in this population.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Ages 18 to 60 years
  • Diagnosis of HIV-1 infection
  • Receiving antiretroviral therapy with a triple regimen (Biktarvy treatment)
  • Undetectable viral load (< 20 copies/mL) for the past 6 months CD4+ level > 200 cells/μL
  • Diagnosis of mixed dyslipidemia in the last three months, indicated by:
  • Total cholesterol ≥ 200 mg/dL
  • HDL cholesterol < 40 mg/dL in men and < 50 mg/dL in women
  • LDL cholesterol > 100 mg/dL
  • Triglycerides ≥ 150 mg/dL
  • Possession of a mobile device or computer with internet access and necessary platforms
  • Willingness to participate voluntarily in the study and provide written consent

排除标准

  • Individuals who develop hypersensitivity or allergy to ginkgo biloba extract
  • Failure to attend at least 80% of the physical exercise sessions (equivalent to missing more than 12 sessions)
  • Lack of adherence to pharmacological treatment
  • Participant's decision to discontinue the intervention

研究组 & 干预措施

Ginkgo biloba group

Experimental

This group will assess the effects of aerobic exercise combined with ginkgo biloba extract

干预措施: Aerobic exercise + Ginkgo Biloba Extract (Drug)

Placebo group

Placebo Comparator

Participants in this group will serve as a control to evaluate the effects of aerobic exercise when administered a placebo of calcined magnesia

干预措施: Aerobic exercise + Calcined magnesia (placebo) (Drug)

Statins group

Active Comparator

In this group, the effects of aerobic exercise along with the administration of atorvastatin will be investigated

干预措施: Aerobic exercise + Atorvastatin (Drug)

结局指标

主要结局

Comparison of changes in serum lipid levels.

时间窗: 12 weeks

Levels of Total Cholesterol (mg/dL), HDL (High-Density Lipoprotein) (mg/dL), LDL (Low-Density Lipoprotein) (mg/dL), VLDL (Very Low-Density Lipoprotein) (mg/dL) and, Triglycerides (mg/dL) will be assessed

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Raul Soria Rodriguez, PhD

Associate Research Professor

University of Guadalajara

研究点 (1)

Loading locations...

相似试验